arrow_back Back Filing freshness 10-Q Q3 FY2026 SEC EDGAR

Rafael Holdings, Inc.

RFL
$2.03 ▲ +0.01 (+0.50%) at close
Healthcare ·Pharmaceutical Preparations ·USPharmaceutical Preparations
41 Visible periods
28 Metrics
Peer-ranked Benchmarks
Price Chart
25
Health
Poor
Bearish
auto_awesome

Analytical Summary

Rafael Holdings, Inc. faces fundamental challenges with weakness in Return on Common Equity (%). The fundamentals warrant careful consideration of downside risks.

Market Cap $104.0M
Dividend Yield —
Revenue Growth -50.6% ↘
Op. Margin None
ROIC -9.1% ↘
FCF / Share $-0.14 ↗
Trailing P/E —
Price / Book 1.4x
FCF Yield —
Debt / Equity —
info Valuation on last close. End-of-day price, Sep 23, 2026.

41-Year Financial Trajectory

Quarterly
Metric Value Trend Year over Year Percentile
Revenue Total top-line sales
$179.00K
↓ -50.6% —
Net Income Profit after all expenses
$-4.23M
↑ +11.6% —
Operating Margin Operating profit as % of sales
-351.4%
↓ -48.6% —
FCF / Share Free cash flow per share
$-0.14
↑ +3.2% —
trending_up

Bullish Indicators

  • No bullish signals detected.
warning

Bearish Risks

  • Return on Common Equity (%)Return on Common Equity (%) is in the bottom quartile

Health Breakdown

Returns ↓
22
Financial Health ↑
18
Cash Quality ↓
45

bar_chart Data from SEC EDGAR XBRL filings

Synced yesterday 11 years · 41 quarters